108938-16-5Relevant articles and documents
Bicyclic heteroaryl compound with PAR4 antagonistic activity and application thereof
-
Paragraph 0074-0076; 0079, (2020/08/02)
The invention discloses a bicyclic heteroaryl compound with PAR4 antagonistic activity and application thereof. The invention provides the bicyclic heteroaryl compound with PAR4 antagonistic activity,and the bicyclic heteroaryl compound has remarkable antagonistic activity on PAR4 in an in-vitro anti-platelet aggregation experiment, so that platelet aggregation is effectively inhibited, and the bicyclic heteroaryl compound can be used for preparing medicines for preventing or treating various thromboembolic diseases.
Synthesis of some Newer Biologically Active Substituted-3-((6-substituted-2-hydrazono)benzothiazolyl)-2-indolines. Part LIV
Varma, R. S.,Tewari, Manju
, p. 39 - 41 (2007/10/02)
5-Bromo- and 5-methyl-7-bromoisatins (1a) have been synthesised and transformed into the corresponding 1-methyl analogs (1b). 1a and 1b have been condensed with 2-hydrazinobenzothiazoles to yield 3 and 4.Mannich condensation of 3 using morpholine and piperidine furnished the corresponding 1-morpholino/piperidinomethyl analogs (5).The compounds have been characterised by means of ir and pmr spectroscopy.